Program in Translational Therapeutics


To promote and accelerate early phase clinical development of novel translational therapeutics by building matrix partnerships between interdisciplinary and inter-institutional laboratory and clinical investigators.

Goals include:

  1. To extend and expand the critical mass of expertise and leadership in Translational Therapeutics that is an identifiable resource for trainees and both intra- and extra-mural collaborators.
  2. To facilitate translational therapeutics with engineered cells.
  3. To promote translational science using engineered RNA and targeted nanomedicines.
  4. To address the emerging disparities that restrict access to novel cell and gene therapies.

PTT Co-Directors

Carl June, MD – Professor
Department of Pathology and Laboratory Medicine
Director of Translational Research of the Abramson Cancer Center

Drew Weissman, MD, PhD
Department of Medicine 
Co-Director, Penn Center for AIDS Research, Immunology Core

General inquiries can be sent to